AKT1 and hepatocellular carcinoma: Furthermore, pharmacological blockade of Akt signalling attenuated the progression of hepatocarcinogenesis in MK-2206-treated fish, suggesting that the use of these transgenic fish models for drug screening could benefit the treatment of HCC patients.